ClinicalTrials.gov 临床试验·· 29 天前AI 评分38
VIC-1911联合环磷酰胺与西罗莫司预防儿童单倍体造血干细胞移植后GVHD的Ib期临床研究
A Preliminary Clinical Study on the Efficacy of Cyclophosphamide and Sirolimus Combined With VIC-1911 in Preventing Graft-versus-Host Disease After Haploidentical Stem Cell Transplantation in Children
AI 导读
一项单臂、开放标签Ib期临床试验启动,评估VIC-1911片联合PTCy(环磷酰胺)与西罗莫司预防儿童单倍体造血干细胞移植后GVHD的安全性、PK/PD特征及初步疗效。
来源:ClinicalTrials.gov 临床试验 · clinicaltrials.gov